SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13D/A - General Statement of Acquisition of Beneficial Ownership: [Amend]
SEC Accession No. 0000921895-09-002926
Filing Date
2009-12-24
Accepted
2009-12-24 16:01:15
Documents
1

Document Format Files

Seq Description Document Type Size
1 AMENDMENT NO. 9 TO THE SCHEDULE 13D sc13da907422003_12182009.htm SC 13D/A 206996
  Complete submission text file 0000921895-09-002926.txt   208952
Mailing Address 900 N. MICHIGAN AVENUE, SUITE 1100 CHICAGO IL 60611
Business Address 900 N. MICHIGAN AVENUE, SUITE 1100 CHICAGO IL 60611 3125066500
BIOTECHNOLOGY VALUE FUND L P (Filed by) CIK: 0000918923 (see all company filings)

IRS No.: 363924731 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13D/A
SIC: 6282 Investment Advice

Mailing Address 1301 HARBOR BAY PARKWAY ALAMEDA CA 94502
Business Address 1301 HARBOR BAY PARKWAY . ALAMEDA CA 94502 5107487150
AVIGEN INC \DE (Subject) CIK: 0000932903 (see all company filings)

IRS No.: 133647119 | State of Incorp.: DE | Fiscal Year End: 1121
Type: SC 13D/A | Act: 34 | File No.: 005-48313 | Film No.: 091260414
SIC: 2835 In Vitro & In Vivo Diagnostic Substances